Error: Could not add to watchlist. X
+ Watchlist

Transition Therapeutics Inc

TTH:CN
Acquired
TTH:CN was acquired by OPK:US
2.00
CAD
As of 3:59 PM EDT 8/30/2016
Volume
4
52Wk Range
0.89 - 3.54
Volume
4
52Wk Range
0.89 - 3.54
YTD Return
-22.78%
Current P/E Ratio (TTM)
-
Earnings per Share (CAD) (TTM)
-0.64
Market Cap (m CAD)
77.598
Shares Outstanding (m)
38.799
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Transition Therapeutics Inc. is a biopharmaceutical company focused on developing novel therapeutics in order to address global medical needs in large disease indications, including Alzheimer's disease and diabetes.
Address
101 College Street
Suite 220
Toronto, ON M5G 1L7
Canada
Phone
1-416-260-7770
Show More